Smith Kirsten E, Feldman Jeffrey D, Dunn Kelly E, McCurdy Christopher R, Weiss Stephanie T, Grundmann Oliver, Garcia-Romeu Albert, Nichels Janeen, Epstein David H
Real-World Assessment, Prediction, and Treatment Unit, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, United States.
Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Front Pharmacol. 2023 May 5;14:1174139. doi: 10.3389/fphar.2023.1174139. eCollection 2023.
Surveys and case reports have documented kratom use in the United States (US) for over a decade. However, those reports have generally not examined in depth the role kratom plays in the lives of those who use it regularly for sustained periods. Until there are controlled studies of the pharmacology and subjective effects of kratom alkaloids in humans, one of the best sources of insight on kratom-product use remains qualitative data with nuanced descriptions of kratom effects from those who use it regularly. We conducted semistructured qualitative interviews with adults who regularly use kratom products, as part of a laboratory study of kratom-product self-administration. This qualitative component of the study was conducted as a narrative case-report series ( = 10). Despite some differences among participants, all experienced acute combination effects that were largely, even simultaneously, analgesic and stimulatory. Most participants had decreased their dosages over time, and one planned to quit. Five of the 10 participants met DSM-5-based criteria for kratom-use disorder (3 mild, 1 moderate, 1 severe, by symptoms counts). When kratom was inadvertently taken in larger than intended doses, participants described a constellation of symptoms that they called "the wobbles" (a jittery feeling accompanied by what seemed to be nystagmus); this was rare, but could be of scientific and clinical interest as a possible manifestation of serotonin syndrome. Most participants described tolerance but considered kratom generally safe at low-moderate doses, providing perceived benefits with less potential risk for adverse effects compared to pharmaceuticals or illicit drugs. In-depth interview data like these help confirm and clarify findings from larger survey studies and clinician-driven case reports. They are needed to inform the policy practice regarding kratom and may also help inform future experimental designs.
调查和病例报告显示,在美国,人们使用 kratom 已有十多年历史。然而,这些报告通常并未深入研究 kratom 在长期经常使用它的人群生活中所起的作用。在对 kratom 生物碱在人体中的药理学和主观效应进行对照研究之前,了解 kratom 产品使用情况的最佳信息来源之一仍然是定性数据,这些数据来自经常使用 kratom 的人对其效果的细致描述。作为 kratom 产品自我给药实验室研究的一部分,我们对经常使用 kratom 产品的成年人进行了半结构化定性访谈。该研究的这一定性部分作为一个叙事性病例报告系列(n = 10)进行。尽管参与者之间存在一些差异,但所有人都经历了急性联合效应,这些效应在很大程度上甚至同时具有镇痛和刺激作用。随着时间的推移,大多数参与者减少了剂量,其中一人计划戒烟。10 名参与者中有 5 人符合基于《精神疾病诊断与统计手册》第 5 版(DSM - 5)的 kratom 使用障碍标准(根据症状计数,3 例轻度、1 例中度、1 例重度)。当 kratom 意外服用剂量大于预期时,参与者描述了一系列他们称之为“摇晃感”的症状(一种伴有似乎是眼球震颤的紧张感);这种情况很少见,但作为血清素综合征的一种可能表现,可能具有科学和临床研究价值。大多数参与者描述了耐受性,但认为 kratom 在低至中等剂量下总体安全,与药物或非法药物相比,它能带来明显益处且潜在不良反应风险较低。这样的深入访谈数据有助于证实和阐明大型调查研究以及临床医生主导的病例报告的结果。它们对于为有关 kratom 的政策实践提供信息是必要的,也可能有助于为未来的实验设计提供参考。